|Publication number||US3390049 A|
|Publication date||Jun 25, 1968|
|Filing date||Dec 23, 1964|
|Priority date||Dec 23, 1964|
|Also published as||DE1492156A1, DE1492156B2, DE1492156C3|
|Publication number||US 3390049 A, US 3390049A, US-A-3390049, US3390049 A, US3390049A|
|Inventors||Michael Secora, Reduick Alvin B|
|Original Assignee||Smith Kline French Lab|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (12), Referenced by (22), Classifications (17), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 3,390,049 PHARMACEUTICAL TABLETS COATED WITH WAX-FREE AMMONIA SOLUBILIZED WATER SOLUBLE SHELLAC Alvin B. Rcdnicit, Cherry Hill, N.J., and Michael.
Secora, Phiiadelphia, Pa., assignors to Smith Kline & French Laboratories, Philadelphia, Pin, a corporation of Pennsylvania No Drawing. Filed Dec. 23, 1964, Ser. No. 420,771 3 Claims. (Cl. 167-82) ABSTRACT OF THE DIStlLOSURE Thin film coated pharmaceutical forms which employ a water soluble shellac as the coating material. Wax-free shellac is rendered water soluble by dissolving it in ammonia and Water resulting in a water permeable coating.
This invention relates to a novel film coating composition for solid pharmaceutical forms such as compressed tablets, pills, pellets and the like, a pharmaceutical form substantially covered with said coating and a rapid and inexpensive process for coating said forms.
More specifically this invention relates to coated pharmaceutical forms having a novel film coating which has as a main ingredient Water soluble shellac.
Shellac is Well known as a coating material in the art. However, whenever shellac is employed as a coating agent for a pharmaceutical form the prior art reveals that the coated product is either enteric or sustained release in nature. In other words when a tablet is coated with shellac the prior art teaches that the tablet will possess a delayed release of medicament.
Further, shellac has been utilized to cover tablets that have been previously sugar coated in order to facilitate printing or to provide a waterproof or moisture barrier for a tablet core prior to sugar coating. In each instance sugar coating of the tablet is an additional step.
The process of sugar coating tablets embraces the following time consuming coating steps:
(a) waterproofing and sealing,
(c) rounding or smoothing coats, (d) coloring and finishing coats and (e) polishing.
This amounts to approximately 80 total coats and takes days to complete. This total time is required not only because of the number of coats necessary but also because of the drying cycle needed before applying the next coat.
Disadvantages associated with the build up of sugar coating layers are obvious. For example, sugar coating cannot be used for coating scored or grooved tablets and tablets with engraved monograms because the total number of coats required obliterates the groove and monogram. Further, due to the multiple coatings the finished tablet is approximately 50% greater in volume or usually double the weight of the uncoated tablet. A still further drawback is that the tablet must be compressed relatively hard in order to withstand the vigorous rolling and tumbling in the coating pan. This hard compression often results in a delay in disintegration time.
When the novel coating composition is applied to pharmaceutical forms according to the process of this invention it is possible to obtain a fast drying, thin, transparent film coat. Sugar coating with all of its build up steps is completely eliminated. The time required to coat the tablets is reduced from days to minutes because of the relatively few coats that are necessary. Therefore, in
3.3%,049 Patented June 25, 1968 accordance with this invention it is now possible to coat tablets rapidly and inexpensively. The thin, transparent film allows for the monogramming and. scoring of the compressed tablet. Furthermore, the constituents of the film are all materials readily used for human consumption.
More important the tremendous reduction of the number of coats also results in the production of a much smaller finished tablet. This feature allows for a more pharmaceutically elegant tablet which is much easier for the patient to swallow.
It has been unexpectedly discovered that when shellac is rendered water soluble as described hereinafter a superior thin film coating for tablets results. Such water soluble shellac no longer delays the release of the tablet but contrary to the prior art teachings results in an immediate release of the tablet. Still further, contrary to prior art teachings the shellac as treated according to the process of this invention no longer acts as a Waterproof or moisture barrier but as a thin water permeable tablet coating.
The coating composition of this invention is comprised of wax free shellac which is rendered Water soluble by dissolving the shellac in water and ammonia until a solution results. Other ingredients such as plasticizing agents, opaquing agents and coloring materials may be added to the coating solution to enhance the properties of the coating.
Preferably the shellac will be present in an amount of from about 0.1% to about 5% by weight of the total coating composition advantageously from about 1% to about 3% by weight of the total coating composition. The ratio of water and ammonia to the wax free shellac would be evident to one skilled in the art, using just enough necessary to dissolve the shellac. Preferably twice as much water and 28% ammonia solution (U.S.P.) used in a ratio of from about 10:1 to about 30:1 is used to dissolve the shellac. If desired an or anic solvent may be added to the above shellac concentrate to hasten the evaporation of the coating.
When plasticizers are advantageously employed in the coating composition they will be present in an amount of from about 0.5% to about 15% by weight of the total coating composition preferably from about 1% to about 10% by Weight of the total coating composition. Among the plasticizing agents which may be employed are any of those well known to the art, such as for example, solid polyethylene glycol, polyvinylpyrrolidone, dibutyl phthalate, dimethyl phthalate, diisobutyi adipate, castor oil, mineral oil, propylene glycol, stearyl alcohol, cetyl alcohol and the glyceridcs of higher fatty acids.
Most advantageously solid polyethylene glycol and polyvinylpyrrolidone are used either alone or preferably a mixture of both as plasticizers in carrying out the method of this invention. When this novel combination of water soluble shellac, solid polyethylene glycol and polyvinylpyrrolidone is employed it imparts improved iiowability and results in a coating composition which is more flexible and smoother. Further, the added ingredient, solid polyethylene glycol also acts as an anti-tacking agent and prevents the sticking of the tablets to one another as they are rotated in the coating pan. Finally, the use of a solid polyethylene glycol, such as for example, polyethylene glycol 6000, adds gloss to the tablet coat and eliminates the necessity of a final separate polish coating.
The polyethylene glycols used in the coating composition of this invention are solid, waxy materials having a molecular weight as high as 20,000. Preferably the polyethylene glycols employed will have a molecular weight of from about 1,000 to about 10,000. These solid poly- 9 ethylene glycols are well known in the art and sold under the tradename of Carbowax.
When coloring materials are desired, any of the nontoxic pigments, lakes and dyes which have been certified for use in the food, drug and cosmetic industries may be used. The nontoxic coloring agent, when employed will be present in an amount to provide the desired color and shade preferably from about 0.05% to about 1% by weight of the total coating composition. Exemplary of the preferred dyes and lakes are those coal tar colors listed under their Food and Drug Administration designations such as, for example FD & C blue No. 6, D 8; C blue No. 9, D & C green No. 6, D 8: C violet No. 2, D 8: C red No. 17, D & C orange No. 5, D 81 C yellow No. 7, D & C green No. 1, PD & C yellow No. 6 lake, FD & C blue No. 2 lake, FD & C red No. 2 lake, FD & C violet No. 1 lake and FD & C green No. 3 lake.
Advantageously the compositions of this invention may also contain a substantially water insoluble, colorless, nontoxic opaque material such as calcium carbonate, barium sulfate or preferably titanium dioxide. The nontoxic opaque constituent when employed will amount to from about 0.25% to about by weight of the coloring composition.
The novel coating composition is prepared by first forming the shellac concentrate by dissolving the wax free shellac and when employed, the plasticizer in Water and strong ammonia solution. The shellac concentrate is then diluted with organic solvents, such as for example, alcohol and chloroform containing either the dye, pigment or lake. The coating composition is now ready for use and it may be poured or sprayed on the solid pharmaceutical forms.
The method of coating the solid pharmaceutical forms such as compressed tablets, pills, pellets, troches and the like in accordance with this invention comprises placing said solid forms, as for example tablets containing a medicament and filler, in a coating pan. The tablets are thoroughly and evenly wetted with the coating solution. The tablets are dried while rotating in the coating pan. Advantageously air is passed over the tablets during the drying process. Further coats are applied by repeating the above procedure. Normally 10 to coats are sufficient, more can be applied if desired. The coated tablets can be polished or not as desired.
The solid pharmaceutical forms which are also an important aspect of this invention are solid pharmaceutical forms such as tablets, pills, pellets, troches and the like substantially completely coated with a film forming polymer containing water soluble shellac as defined above. These forms are comprised of a core containing the medicament normally with a filler surrounded by said film forming polymer. The thickness of said coatings advantageously is in the range of from about 0.0001 to about 0.002" preferably from about 0.0005" to about .001". Generally it is satisfactory for the coating to be from about 0.3% to about 3% of the total weight of the tablet, preferably from about 0.5% to about 2% and as indicated above it substantially completely covers the core form.
Tablets coated using this procedure and coating composition yield a smooth glossy coat. The total thickness of the combined coats is such that the detail of the surface of the core is retained, for instance monograms or scores.
The following examples are not limiting and are used to specifically illustrate the coating composition and will make obvious to one skilled in the art the full practice of the method of this invention.
Example 1.Shellac concentrate-Solution A Ingredients: Percent w./v. Wax free shellac 15.34
Polyvinylpyrrolidone 15.34 Carbowax 6000 14.32 Strong ammonia solution 28% (U.S.P.) 1.53
Water, q.s., 100.00 ml.
4- The shellac, polyvinylpyrrolidone and Carbowax are dissolved in the strong ammonia solution and water with the aid of heat to form a shellac concentrate.
Solution B Ingredients: Amount Shellac concentrate ml 300 Isopropyl alcohol ml 4500 Chloroform ml 600 Titanium dioxide gms 180 ED & C yellow No. 5 lake gms 18 The shellac concentrate, isopropyl alcohol and chloroform are mixed and the titanium dioxide and FD & C yellow No. 5 lake are suspended in the mixture with continued agitation to form the coating composition. Tablet cores of inch diameter containing trifiuoperazine and filler are placed in a rotating 12 inch coating pan and are thoroughly and evenly wetted by spraying on the above coating composition. The tablets are dried while being rotated and passing air over them. This procedure is followed until approximately 15 coats have been applied leaving a hard thin film coat on the tablets.
Example 2.Shellac concentrate--Solution A Ingredients: Percent w./v. Wax free shellac 20.4 Strong ammonia solution 28% (U.S.P.) 2.04 Distilled water, q.s., 100.00 ml.
The shellac is dissolved in the strong ammonia solution and the water with stirring and the application of heat, approximately heated to C.
Solution B Ingredients: Amount, ml. Shellac concentrate Isopropyl alcohol 4500 Chloroform 600 The shellac concentrate, isopropyl alcohol and chloroform are thoroughly mixed to form the coating composition.
Tablet cores containing dextroamphetamine and filler are placed in a rotating 12 inch coating pan and are thoroughly and evenly wetted by spraying on the above coating composition. The tablets are dried While being rotated and passing air .over them. This procedure is followed until approximately 15 coats have been applied leaving a hard thin film coat on the tablets.
Example 3.Shellac concentrateSolution A Ingredients: Percent w./v. Wax free shellac 16.0
Carboxaw 6000 15.0 Strong ammonia solution 28% (U.S.P.) 1.6
Water, q.s., 100.0 ml.
The shellac and Carboxaw are dissolved in the strong ammonia solution and water with the aid of heat to form a shellac concentrate.
Solution B Ingredients: Amount Shellac concentrate ml 200 Isopropyl alcohol ml 4500 Chloroform ml 600 FD & C Yellow No. 5 gms 1.8
The shellac concentrate, chloroform and alcohol which has the FD & C Yellow No. 5 added are thoroughly mixed to form the coating composition.
Tablet cores containing chlorpromazine hydrochloride and filler are placed in a rotating 12 inch coating pan and are thoroughly and evenly wetted by spraying on the above coating composition. The tablets are dried while being rotated and passing air over them. This procedure is followed until approximately 15 coats have been applied leaving a hard thin film coat on the tablets.
What is claimed is:
1. A film-coated pharmaceutical form comprising a solid medicament-containing core, that has not been previously coated having a coating that provides neither a water-proof or moisture barrier nor is enteric or sustained release in nature comprising from about 10 to about 20 coats of Wax-free ammonia solubilizecl water soluble shellac, said coating being from 0.0005 inch to about 0.0-01 inch thick and being from about 0.3% to about 3.0% of the total weight of the tablet.
2. A film-coated pharmaceutical form comprising a solid medicament-containing core that has not been previously coated having a coating that provides neither a Waterproof or moisture barrier nor is enteric or sustained release in nature comprising from about 10 to about 20 coats of Wax-free ammonia solubilized Water soluble shellac and a plasticizer selected from the group consisting of polyvinylpyrrolidone or solid polyethylene glycol said coating being from 0.0005 inch to about 0.001 inch thick and being from about 0.3% to about 3.0% of the total weight of the tablet.
3. A film-coated pharmaceutical form comprising a solid medicament-containing core that has not been previously coated having a coating that provides neither a water-proof or moisture barrier nor is enteric or substained release in nature comprising from about 10 to about 20 coats of wax-free ammonia solubilized Water soluble shellac and solid polyethylene glycol said coating being from about 0.3% to about 3.0% of the total weight of the tablet.
References Cited UNITED STATES PATENTS 2,865,810 12/1958 Sanders 167-82 2,954,322 9/1960 Heilig et 'al 167-82 3,097,144 7/1963 Banker 167-82 3,149,039 9/1964 Jetfries 167-82 3,149,041 9/1964 Ietlfries 167-82 3,173,839 3/1965 Nicholson 167-82 3,256,153 6/1966 Heimlich 167-82 3,297,535 1/1967 Butler et a1. 167-82 2,450,959 10/1948 Heinecke 106-30 2,678,278 5/1954 Schmitzler 106-30 2,982,234 5/1961 Ackley et a1. 107-54 2,245,100 6/1941 Bernstein 134-36 LEWIS GOTTS, Primary Examiner.
S. K. ROSE, Assistant Examiner.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2245100 *||Dec 24, 1938||Jun 10, 1941||Interchem Corp||Method of making pigmented acid resin emulsion|
|US2450959 *||Aug 11, 1945||Oct 12, 1948||William Heinecke||Silk screen printing ink|
|US2678278 *||Feb 29, 1952||May 11, 1954||Schmutzler Alfred F||Anhydrous moisture-sensitive printing ink vehicle|
|US2865810 *||Oct 7, 1955||Dec 23, 1958||Sanders Jr Roy Y||Marked pharmaceutical tablet and method of marking the same|
|US2954322 *||Sep 4, 1958||Sep 27, 1960||Olin Mathieson||Pharmaceuticals|
|US2982234 *||Oct 4, 1957||May 2, 1961||Hartnett Co R W||Method of printing waxed pellets, and printing ink|
|US3097144 *||Oct 14, 1960||Jul 9, 1963||Upjohn Co||Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol|
|US3149039 *||Oct 3, 1961||Sep 15, 1964||Dow Chemical Co||Thin film coating for tablets and the like and method of coating|
|US3149041 *||Apr 9, 1962||Sep 15, 1964||Dow Chemical Co||Thin film coating for tablets and the like and method of coating|
|US3173839 *||Jan 9, 1962||Mar 16, 1965||Smith Kline French Lab||Method of printing pharmaceutical forms|
|US3256153 *||Feb 8, 1963||Jun 14, 1966||Smith Kline French Lab||Method of stabilizing wax-fat coating materials and product thereof|
|US3297535 *||Feb 28, 1963||Jan 10, 1967||Hoffmann La Roche||Shellac tablet coating compositions and methods of preparation|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3539481 *||Jun 17, 1968||Nov 10, 1970||Us Plywood Champ Papers Inc||Adhesive stick|
|US3625933 *||Oct 29, 1969||Dec 7, 1971||Us Plywood Champ Papers Inc||De khotinsky cement|
|US3992515 *||Nov 15, 1974||Nov 16, 1976||Johnson Vernon S||Composition for indicating and method of removing dental undercuts and the like|
|US4661359 *||Jun 3, 1985||Apr 28, 1987||General Mills, Inc.||Compositions and methods for preparing an edible film of lower water vapor permeability|
|US4710228 *||Oct 16, 1985||Dec 1, 1987||General Mills, Inc.||Edible coating composition and method of preparation|
|US4874618 *||Nov 3, 1987||Oct 17, 1989||General Mills, Inc.||Package containing a moisture resistant edible internal barrier|
|US5194464 *||Mar 23, 1990||Mar 16, 1993||Takeda Chemical Industries, Ltd.||Enteric film and preparatoin thereof|
|US5567438 *||Oct 12, 1995||Oct 22, 1996||Opta Food Ingredients, Inc.||Shellac dispersions and coatings, and method of forming aqueous-based shellac dispersions and coatings|
|US5800601 *||Mar 14, 1997||Sep 1, 1998||Videojet Systems International, Inc.||Food grade jet inks|
|US6747072 *||Jan 22, 1997||Jun 8, 2004||Marconi Data Systems Inc.||White ink for marking candy substrates|
|US6893671 *||Dec 15, 2000||May 17, 2005||Mars, Incorporated||Chocolate confectionery having high resolution printed images on an edible image-substrate coating|
|US7858129 *||Oct 28, 2005||Dec 28, 2010||Emerson Resources, Inc.||High gloss film coating and stable solution therefor|
|US7993673 *||Jun 3, 2002||Aug 9, 2011||Smithkline Beecham Limited||Swallow tablet comprising paracetamol|
|US8216610||Jul 10, 2012||Imaginot Pty Ltd.||Oral paracetamol formulations|
|US20020114878 *||Dec 15, 2000||Aug 22, 2002||Ben-Yoseph Eyal M.||Chocolate confectionery having high resolution printed images on an edible image-substrate coating|
|US20040170681 *||Jun 3, 2002||Sep 2, 2004||Grattan Timothy James||Swallow tablet comprising paracetamol|
|US20060040042 *||Oct 28, 2005||Feb 23, 2006||Emerson Resources, Inc.||High Gloss Film Coating and Stable Solution Therefor|
|US20070141144 *||Nov 27, 2006||Jun 21, 2007||Roberts Michael S||Oral delivery system|
|US20080287456 *||May 27, 2005||Nov 20, 2008||Imaginot Pty Ltd||Oral Therapeutic Compound Delivery System|
|US20090311327 *||Nov 28, 2006||Dec 17, 2009||Imaginot Pty Ltd||Oral Therapeutic Compound Delivery System|
|WO2006092663A2 *||Sep 22, 2005||Sep 8, 2006||Carey & Cia Ltd||Non-bleeding and edible color film coating for seeds and the like|
|WO2006092663A3 *||Sep 22, 2005||Aug 16, 2007||Denis Gustavo Berndt||Non-bleeding and edible color film coating for seeds and the like|
|U.S. Classification||424/481, 106/241, 530/201, 106/218, 106/237, 106/236, 106/240, 106/238|
|International Classification||A61K9/30, A61K9/28, A61K9/32|
|Cooperative Classification||A61K9/2853, A61K9/284, A61K9/282|
|European Classification||A61K9/28H4, A61K9/28H6D, A61K9/28H6B|
|Jun 21, 1982||AS||Assignment|
Owner name: SMITHKLINE BECKMAN CORPORATION
Free format text: CHANGE OF NAME;ASSIGNOR:SMITHKLINE CORPORATION;REEL/FRAME:004080/0769
Effective date: 19820304
Owner name: SMITHKLINE BECKMAN CORPORATION, PENNSYLVANIA